Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sequential administration of 5-fluorouracil (5FU)/leucovorin (LV) followed by irinotecan (CPT-11) at relapse versus CPT-11 followed by 5-FU/LV in advanced colorectal carcinoma. A phase III randomized study.
Tsavaris N, Kosmas C, Skopelitis H, Papadoniou N, Polyzos A, Zografos G, Adoniou E, Gryniatsos J, Felekouras E, Zacharakis M, Sigala F, Bacoyiannis C, Papastratis G, Papalambros E. Tsavaris N, et al. Among authors: bacoyiannis c. Chemotherapy. 2007;53(4):282-91. doi: 10.1159/000102583. Epub 2007 May 10. Chemotherapy. 2007. PMID: 17496414 Clinical Trial.
Biochemical modulation of fluorouracil: comparison of methotrexate, folinic acid, and fluorouracil versus folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial.
Polyzos A, Tsavaris N, Giannopoulos A, Bacoyiannis C, Papadimas V, Kalahanis N, Karatzas G, Kosmas C, Sakelaropoulos N, Archimandritis A, Papachristodoulou A, Kosmidis P. Polyzos A, et al. Among authors: bacoyiannis c. Cancer Chemother Pharmacol. 1996;38(3):292-7. doi: 10.1007/s002800050485. Cancer Chemother Pharmacol. 1996. PMID: 8646806 Clinical Trial.
Combined treatment with low-dose interferon plus vinblastine is associated with less toxicity than conventional interferon monotherapy in patients with metastatic renal cell carcinoma.
Tsavaris N, Skarlos D, Bacoyiannis C, Aravantinos G, Kosmas C, Retalis G, Panopoulos C, Vadiaka M, Dimitrakopoulos A, Kostantinidis K, Mitropoulos D, Bougas D, Pantazopoulos D, Kosmidis P. Tsavaris N, et al. Among authors: bacoyiannis c. J Interferon Cytokine Res. 2000 Aug;20(8):685-90. doi: 10.1089/10799900050116381. J Interferon Cytokine Res. 2000. PMID: 10954911 Clinical Trial.
33 results